{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:07:28Z","timestamp":1792382848015,"version":"4.4.0"},"reference-count":76,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>\n                    Recurrent cystitis is a common problem in women that substantially impairs quality of life and contributes to increasing healthcare costs. Traditionally regarded as an ascending infection originating from the gut, recurrent cystitis is now increasingly understood as a disorder rooted in vaginal dysbiosis, with the vagina acting as a key reservoir for uropathogenic\n                    <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                    . Loss of a\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    -dominant vaginal microbiota and overgrowth of enteric and anaerobic bacteria are strongly associated with recurrent cystitis, particularly in postmenopausal women.\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    species promote vaginal health by producing lactic acid, maintaining a low pH, generating antimicrobial compounds, inhibiting pathogen adhesion, and modulating mucosal immune responses. At the same time, long-term antimicrobial prophylaxis, although effective in reducing recurrences, is limited by adverse effects and the promotion of antimicrobial resistance. These concerns have driven interest in strategies that restore the protective vaginal ecosystem rather than relying on repeated antimicrobial exposure. This narrative review summarizes current concepts linking vaginal dysbiosis to recurrent cystitis, highlights the protective role of\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    , and synthesizes clinical data on\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    vaginal suppositories, particularly\n                    <jats:italic toggle=\"yes\">Lactobacillus crispatus<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">L. crispatus<\/jats:italic>\n                    )-based preparations, as a targeted, non-antimicrobial prophylactic option. Across pilot, phase II, and randomized trials,\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    vaginal therapy has demonstrated a generally favorable safety and tolerability profile, with preliminary evidence suggesting a potential to reduce recurrent cystitis episodes while restoring a\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    -dominant vaginal microbiota. However, larger, standardized studies are still needed. Collectively, these findings provide a rationale for investigating\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    vaginal suppositories as a microbiome-informed, non-antimicrobial strategy for the long-term prevention of recurrent cystitis, particularly in postmenopausal and other high-risk women, and highlight the importance of further research to define the role of vaginal microbiota-directed therapies in future recurrent cystitis management.\n                  <\/jats:p>","DOI":"10.1177\/17562872261448600","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:33:03Z","timestamp":1778243583000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the vaginal microbiota-based etiology of recurrent cystitis: the potential role of\n                    <i>Lactobacillus<\/i>\n                    vaginal suppositories"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-7429","authenticated-orcid":false,"given":"Takanori","family":"Sekito","sequence":"first","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetada","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Gunma University Graduate School of Medicine, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sadahira","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1, Shikata-cho, Kita-ku, Okayama 700-8558, Japan"},{"name":"Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/jmms12010005"},{"issue":"7","key":"e_1_3_4_3_2","first-page":"560","article-title":"Common questions about recurrent urinary tract infections in women","volume":"93","author":"Arnold JJ","year":"2016","unstructured":"Arnold JJ, Hehn LE, Klein DA. Common questions about recurrent urinary tract infections in women. Am Fam Physician 2016; 93(7): 560\u2013569.","journal-title":"Am Fam Physician"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64397-2"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw396"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1187479"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/378203"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002611107"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127787"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.04.142"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.035"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw424"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X708125"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/microbiolres16030066"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1716604"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004723"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17235"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11010007"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76438-2"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102490"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.05.015"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/515635"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-011-0199-0"},{"issue":"5","key":"e_1_3_4_25_2","first-page":"468","article-title":"Distribution of fimbrial genes and their association with virulence and levofloxacin resistance\/extended-spectrum beta-lactamase production in uropathogenic","volume":"14","author":"Mitsui M","year":"2025","unstructured":"Mitsui M, Sekito T, Maruhashi M, et al. Distribution of fimbrial genes and their association with virulence and levofloxacin resistance\/extended-spectrum beta-lactamase production in uropathogenic Escherichia coli. Antibiotics (Basel) 2025; 14(5): 468.","journal-title":"Escherichia coli. Antibiotics (Basel)"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2444689"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1283"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01346-6"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02785-22"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.073270-0"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00326"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-092611-150157"},{"issue":"5","key":"e_1_3_4_33_2","article-title":"Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against","volume":"9","author":"Ghartey JP","year":"2014","unstructured":"Ghartey JP, Smith BC, Chen Z, et al. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS One 2014; 9(5): e96659.","journal-title":"Escherichia coli. PLoS One"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00284"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10390-5"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01631-09"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2009.11.002"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00193"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001940"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309093291102"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/UPJ.0000000000000513"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04397-z"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004589"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/15409996251363800"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir183"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0025-2016"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.870603"},{"key":"e_1_3_4_48_2","article-title":"Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models","volume":"8","author":"Lewis AL","year":"2020","unstructured":"Lewis AL, Gilbert NM. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect Dis 2020; 8: Doc02.","journal-title":"GMS Infect Dis"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16627-5"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65780-0"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.06.013"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx043"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10080966"},{"issue":"1","key":"e_1_3_4_54_2","first-page":"31823","article-title":"Human vaginal Lactobacillus Jensenii -derived (-)-Terpinen-4-ol restores antibiotic sensitivity by inhibiting efflux pumps in drug resistant E. coli and","volume":"15","author":"Nair VG","year":"2025","unstructured":"Nair VG, Unnikrishnan VK, Muralidharan N, et al. Human vaginal Lactobacillus Jensenii -derived (-)-Terpinen-4-ol restores antibiotic sensitivity by inhibiting efflux pumps in drug resistant E. coli and K. pneumoniae. Sci Rep 2025; 15(1): 31823.","journal-title":"K. pneumoniae. Sci Rep"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-023-00376-8"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.05.008"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14636"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/35387"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-023-05568-4"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad766"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000000749"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00788-6"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.11.006"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11100511"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00313-0"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2001.tb01549.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00081"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.777"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01688.x"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.4.658-672.2003"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2584405"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-024-05928-8"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000001064"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2012.06.012"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-025-00406-7"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308526"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01828-7"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261448600","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562872261448600","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261448600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:17:13Z","timestamp":1778494633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562872261448600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":76,"alternative-id":["10.1177\/17562872261448600"],"URL":"https:\/\/doi.org\/10.1177\/17562872261448600","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"value":"1756-2872","type":"print"},{"value":"1756-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"17562872261448600"}}